Organoids

#3D imaging #Artificial intelligence (AI) #Cell Science #In vitro #Organoids #Webinar

Advancing drug discovery with AI-powered 3D/4D imaging

The FDA’s approval of organoids in preclinical research has catalysed a major shift toward complex in vitro models (CIVM) for drug testing and disease research. The implementation of more biologically relevant phenotypic model formats, however, requires an evolution of imaging and analysis techniques. Traditional 2D high-content analysis (HCA)… Read More

Webinar date:
Supported by Zeiss
#News

Organoid
#High throughput screening #iPSC #Live cell analysis #Organoids #Phenotyping #Stem cells #Webinar

Register now: Learn streamlined hepatic differentiation techniques

The value of stem cells in laboratory and clinical research has been clearly demonstrated through numerous studies, showcasing their potential as models for a wide range of diseases and therapeutic developments. The inherent flexibility of stem cells allows for the development of various tissue types from a single,… Read More

Webinar date:
Supported by Sartorius
#News

Organoid
#High throughput screening #iPSC #Live cell analysis #Organoids #Phenotyping #Stem cells

From iPSCs to Organoids: Streamlined Hepatic Differentiation Techniques

In this webinar, we describe the process of differentiating human iPSCs into hepatocytes using three distinct media types, each supplemented with specific growth factors and cytokines at key stages of differentiation. This method provides a relatively straightforward approach to producing mature hepatic cells, enabling the generation of human hepatic organoids… Read More

Webinar date:
Supported by Sartorius
#Webinars

#3D imaging #Artificial intelligence (AI) #Cell Science #In vitro #Organoids

Advancing drug discovery by combining complex in vitro models with AI-powered 3D/4D image analysis

The FDA’s approval of organoids in preclinical research has catalysed a major shift toward complex in vitro models (CIVM) for drug testing and disease research. The implementation of more biologically relevant phenotypic model formats, however, requires an evolution of imaging and analysis techniques. Traditional 2D high-content analysis (HCA) approaches fall… Read More

Webinar date:
Supported by Zeiss
#Webinars

Organoids
#HUB Organoids #Organoids #Webinar

Closing the translation gap with patient-derived organoids

This advertorial appeared in DDW Volume 25 – Issue 4, Fall 2024 Read the digital issue Earlier this year, DDW hosted a webinar, ‘From patient to petri dish: Replicating disease with patient-derived organoids’, supported by HUB Organoids. The event explored how patient-derived organoids are revolutionising drug discovery by overcoming the limitations… Read More

#Exclusive Content

Lab mouse
#3D cell culture #Animal testing #ESG #Non-animal model (NAM) #Organoids #Pistoia Alliance

77% of researchers not using alternatives to animal testing

New survey findings have revealed that 77% of R&D professionals are not using in vitro cell-based alternatives to animal testing, and only 23% describe themselves as ‘very familiar’ with any kind of animal model alternative. More than 350 survey respondents participated in the survey by The… Read More

#News

Bone marrow organoids
#Drug discovery #Human disease models #Organoids #Preclinical development #Webinar

Are organoids superior to other preclinical models?

Developing new drugs is a complex and often lengthy process. A major roadblock lies in the limitations of traditional preclinical models, which often fail to accurately represent the intricate biology of human patients. Join DDW for a free event on 18 June, 3PM… Read More

Webinar date:
Supported by HUB Organoids
#News

#Biomanufacturing #HUB Organoids #Molecular Devices #Organoids #UK #Wales

UK facility to manufacture organoids for drug discovery

A new facility has opened in Cardiff, UK designed to manufacture patient-derived organoids (PDOs) at scale for use in drug discovery and development. The multi-million-pound facility was custom-built by Molecular Devices to house its bioprocess workflow and bioreactor technology Mary Duseau, President of Molecular… Read More

#News

Organoids
#Drug discovery #Human disease models #Organoids #Preclinical development #Webinar

Discover the latest innovations in organoid model development

Developing new drugs is a complex and often lengthy process. A major roadblock lies in the limitations of traditional preclinical models, which often fail to accurately represent the intricate biology of human patients. Join DDW for a free event on 18 June, 3PM… Read More

Webinar date:
Supported by HUB Organoids
#News

Organoids
#Drug discovery #Human disease models #Organoids #Preclinical development #Webinar

How are patient-derived organoids revolutionising drug discovery?

Developing new drugs is a complex and often lengthy process. A major roadblock lies in the limitations of traditional preclinical models, which often fail to accurately represent the intricate biology of human patients. Join DDW for a free event on 18 June, 3PM… Read More

Webinar date:
Supported by HUB Organoids
#News

Organoid
#Drug discovery #Human disease models #Organoids #Preclinical development #Webinar

Discover how organoids bridge the gap between the lab and clinic

Developing new drugs is a complex and often lengthy process. A major roadblock lies in the limitations of traditional preclinical models, which often fail to accurately represent the intricate biology of human patients. Join DDW for a free event on 18 June, 3PM… Read More

Webinar date:
Supported by HUB Organoids
#News

Organoid
#Drug discovery #Human disease models #Organoids #Preclinical development

From patient to petri dish: Replicating disease with patient-derived organoids

Developing new drugs is a complex and often lengthy process. A major roadblock lies in the limitations of traditional preclinical models. These models often fail to accurately represent the intricate biology of human patients. This webinar explores how patient-derived organoids (HUB Organoids) are revolutionising drug discovery by overcoming these challenges. Read More

Webinar date:
Supported by HUB Organoids
#Webinars

#Cell culture #Cell Science #Nanomedicine / nanotechnology #Organoids #The University of Manchester

Lung organoids provide animal alternative for nanomaterial testing

Lung organoids grown by University of Manchester scientists have been shown to mimic the response of animals when exposed to certain nanomaterials. The study at the University’s NanoCell Biology Lab at the Centre for Nanotechnology in Medicine is published in the journal Nano Today. Read More

#Editor's Choice #News

#ADME / Tox #Cell Science #Organoids #Preclinical development #Preclinical investigations #Toxicology

Beyond animal testing: The rise of organoids in toxicology research

Around 30% of drugs show adverse reactions during human clinical trials despite promising pre-clinical studies. One of the major causes of the high attrition rate is the poor predictive value of current preclinical models used in drug development. Traditional 2D cell cultures often fail to replicate the cellular… Read More

#News

#3D cell culture #ADME / Tox #Cell Science #Organoids #Stem cells

How 3D biology is informing drug discovery

Listen to this article on the DDW Podcast:   DDW Editor Reece Armstrong looks at the advantages and opportunities 3D cell cultures, organoids and stem cells are bringing to drug discovery teams. The use of 2D biology in the pharmaceutical industry has provided researchers with ways to observe how cells… Read More

#Exclusive Content

Kidney on a chip technology
#Kidney disease #Organ-on-a-chip #Organoids #Preclinical investigations #University of Washington

Kidney platforms could reduce animal testing in tox studies

Kidney disease researchers at the University of Washington will use a multimillion-dollar federal grant to advance drug development platforms that would reduce reliance on animal tests. The investigators, in the UW schools of Medicine and Pharmacy, received the $7.3 million award from the National Center for… Read More

#News